SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-026866
Filing Date
2022-12-21
Accepted
2022-12-21 16:11:28
Documents
15
Period of Report
2022-12-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K revb-20221219.htm   iXBRL 8-K 76836
2 EX-3.1 revb-ex3_1.htm EX-3.1 48110
3 EX-10.1 revb-ex10_1.htm EX-10.1 126028
  Complete submission text file 0000950170-22-026866.txt   447110

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT revb-20221219_def.xml EX-101.DEF 15263
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT revb-20221219_pre.xml EX-101.PRE 14587
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT revb-20221219.xsd EX-101.SCH 3781
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT revb-20221219_lab.xml EX-101.LAB 20582
9 EXTRACTED XBRL INSTANCE DOCUMENT revb-20221219_htm.xml XML 8221
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

IRS No.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39603 | Film No.: 221478582
SIC: 2834 Pharmaceutical Preparations